KRRO
Frequency Therapeutics Inc
NASDAQ: KRRO · HEALTHCARE · BIOTECHNOLOGY
$13.49
+6.98% today
Updated 2026-04-30
Market cap
$196.07M
P/E ratio
—
P/S ratio
30.68x
EPS (TTM)
$-12.48
Dividend yield
—
52W range
$5 – $56
Volume
0.2M
Frequency Therapeutics Inc (KRRO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.61M | $-17.02M | $34.22M | $-45.19M | $-32.09M | $-53.65M | $-67.28M | $-60.07M | $-78.56M |
| Capital expenditures | $1.86M | $436000.00 | $1.06M | $6.67M | $4.45M | $5.21M | $7.84M | $17.90M | $518000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | $807000.00 | $1.14M | $2.38M | $4.46M | $7.66M |
| Free cash flow | $-16.48M | $-17.46M | $33.15M | $-51.86M | $-36.54M | $-58.86M | $-75.12M | $-77.98M | $-79.08M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |